Clinical Trial Update: A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery [Phase 2]

View source ↗

Summary

Phase 2 study evaluating danavorexton for obstructive sleep apnea after general anesthesia for abdominal surgery was terminated. The sponsor is Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Danavorexton

Snippet

Sponsor: Takeda | Conditions: Sleep Apnea | Phase 2 | Status: TERMINATED